Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Senhwa Biosciences Inc.
DescriptionOral RNA polymerase I (Pol-I) inhibitor activating the p53 pathway
Molecular Target RNA polymerase I (Pol I) ; p53
Mechanism of ActionRNA polymerase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today